Estimación del riesgo de somatización en pacientes hipertensos

DSpace/Manakin Repository

Estimación del riesgo de somatización en pacientes hipertensos

Show simple item record

dc.contributor.author Obregon, Sebastián.
dc.contributor.author Koretzhy, Martin.
dc.contributor.author Brandani, Laura.
dc.contributor.author Haehnel, Mariana.
dc.contributor.author Maristany, Mariana.
dc.contributor.author Vaisbuj, Fabián.
dc.contributor.author Cadenas, Maria.
dc.date.accessioned 2020-03-02T17:21:04Z
dc.date.available 2020-03-02T17:21:04Z
dc.date.issued 2015-04-01
dc.identifier.citation REVISTA ARGENTINA DE CARDIOLOGÍA / VOL 83 Nº 2 / ABRIL 2015 en_US
dc.identifier.issn 0034-7000
dc.identifier.uri https://riu.austral.edu.ar/handle/123456789/832
dc.description.abstract Background: Somatization in hypertensive patients affects not only their quality of life but also their adherence to treatment and the physician-patient relationship, constituting an expensive health care issue. The possibility of estimating the risk of somatization in these patients could promote an individualized management of their manifestations. Objectives: The goal of this study was to stratify the risk of somatization in a cohort of patients with essential hypertension and to characterize the hemodynamic variables associated with the risk of somatization in hypertensive patients. Methods: A total of 120 subjects undergoing cardiovascular risk assessment were prospectively analyzed and classified in: 1) controlled hypertensive group (CHT) (57%, n=68) and 2) normotensive group (NT) (43%, n=52). The risk of somatization was evaluated using the SCL-90-R symptom ckecklist, and the anxiety and depression scales. The hemodynamic profile was determined using a validated oscillometric method. Results: The risk of somatization was higher in the CHT group independently of the presence of other emotional disorders. In subjects with higher risk of depression or anxiety, the evidence of somatization was greater (p<0.0001). In the CHT group, those who received treatment (n=38) had greater risk of somatization and of sleep disorders compared to those without treatment in the same group. Body mass index was associated with the risk of somatization (p=0.0227) and female sex was a predictor of somatization, anxiety and depression (p=0.001). A direct relationship was observed between cardiac output and depression and somatization, and between the risk of somatization and the product of heart rate and systolic blood pressure at rest. Conclusion: The estimation of the risk of somatization is feasible using a validated and reproducible tool. The frequently consulted symptoms in this condition could be associated with a higher risk of somatization, particularly linked with female sex, body mass index, drug therapy, presence of emotional abnormalities a depression and anxiety, and an hyperdynamic pattern. en_US
dc.language.iso es en_US
dc.publisher Sociedad Argentina de Cardiología en_US
dc.subject Trastornos somatoformes en_US
dc.subject Depresión en_US
dc.subject Ansiedad en_US
dc.subject Hipertensión en_US
dc.subject Rigidez vascular en_US
dc.title Estimación del riesgo de somatización en pacientes hipertensos en_US
dc.type Article en_US


Files in this item

Files Size Format View Description
REVISTA ARGENTI ... OL 83 Nº 2 ABRIL 2015.pdf 227.0Kb PDF View/Open IA - Cadenas

This item appears in the following Collection(s)

Show simple item record

Search DSpace


Advanced Search

Browse

My Account